PROTARA THERAPEUTIC INC (TARA) Stock Balance Sheet
NASDAQ:TARA - Nasdaq - US74365U1079 - Common Stock
| MRQ (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 51.76M | 39.59M | 24.10M | 35.70M | 168.60M | |||
| Marketable Securities | 29.74M | 25.99M | 60.20M | 55.50M | N/A | |||
| Receivables | 0.00 | 242.00K | 500.00K | N/A | N/A | |||
| Other Current Assets | 3.58M | 2.88M | 1.30M | 1.90M | 900.00K | |||
| Total Current Assets | 85.08M | 68.70M | 86.10M | 93.10M | 169.40M | |||
| Non-Current Assets | ||||||||
| PPE Net | 5.62M | 6.56M | 7.90M | 8.90M | 2.30M | |||
| Investments And Advances | N/A | N/A | 17.90M | 39.50M | N/A | |||
| Goodwill | N/A | N/A | 0.00 | 29.50M | 29.50M | |||
| Other Non-Current Assets | 3.38M | 3.69M | 1.40M | 1.60M | 1.90M | |||
| Total Non-Current Assets | 9.01M | 10.25M | 27.20M | 79.50M | 33.80M | |||
| TOTAL ASSETS | 94.09M | 78.95M | 113.30M | 172.60M | 203.20M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 6.35M | 3.71M | 4.20M | 3.30M | 2.00M | |||
| Accounts Payable | 2.29M | 2.43M | 1.60M | 1.00M | 900.00K | |||
| Other Current Liabilities | N/A | N/A | N/A | N/A | N/A | |||
| Total Current Liabilities | 8.64M | 6.15M | 5.70M | 4.30M | 2.90M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 3.66M | 4.48M | 5.50M | 6.40M | 1.00M | |||
| Total Non-Current Liabilities | 3.66M | 4.48M | 5.50M | 6.40M | 1.00M | |||
| TOTAL LIABILITIES | 12.30M | 10.63M | 11.20M | 10.70M | 3.90M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -232.21M | -200.38M | -160.00M | -94.00M | -46.80M | |||
| Additional Paid In Capital | 313.95M | 268.73M | 262.70M | 256.10M | 246.00M | |||
| Common Shares | 21.00K | 11.00K | 0.00 | 0.00 | 0.00 | |||
| Other Shareholders' Equity | 29.00K | -31.00K | -700.00K | -200.00K | N/A | |||
| Shares Outstanding | 20.63M | 11.36M | 11.30M | 11.20M | 11.20M | |||
| Tangible Book Value per Share | 3.96 | 6.01 | 9.04 | 11.82 | 15.15 | |||
| Total Shareholders' Equity | 81.79M | 68.32M | 102.10M | 161.90M | 199.20M | |||
| TOTAL LIABILITIES AND EQUITY | 94.09M | 78.95M | 113.30M | 172.60M | 203.20M | |||
| Statistics | ||||||||
| Current Ratio | 9.85 | 11.17 | 15.11 | 21.65 | 58.41 | |||
| Return On Assets (ROA) | -44.69% | -51.19% | -58.21% | -27.38% | -16.72% | |||
| Return On Equity (ROE) | -51.41% | -59.16% | -64.59% | -29.18% | -17.06% | |||
All data in USD , ROIC based on taxRate of 0.21